Treatment with the BRD4 inhibitor JQ1 or BAY 1238097 blocks BRD4 binding to the super-enhancer and PGC-1α expression, suppresses melanoma cell proliferation in vitro, and inhibits tumor growth in a mouse model [40] (Table 1). The gene discussed is PPARGC1A; the disease is melanoma.